J
Jinming Xu
Researcher at Zhejiang University
Publications - 51
Citations - 1070
Jinming Xu is an academic researcher from Zhejiang University. The author has contributed to research in topics: Medicine & Lung cancer. The author has an hindex of 14, co-authored 40 publications receiving 669 citations.
Papers
More filters
Journal ArticleDOI
Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis
Peiwei Li,Han Wu,Honghe Zhang,Yu Shi,Jinming Xu,Yao Ye,Dajing Xia,Jun Yang,Jianting Cai,Yihua Wu +9 more
TL;DR: Findings provide further indication that postdiagnosis aspirin therapy improved CRC overall survival, especially for patients with positive PTGS2 (COX-2) expression and mutated PIK3CA tumours.
Journal ArticleDOI
Survival Rates After Lobectomy, Segmentectomy, and Wedge Resection for Non-Small Cell Lung Cancer
TL;DR: Although the OS rate was better for lobectomy than for wedge resection, no statistical differences in the LCSS rate were identified among the three treatment groups of patients with tumors that were 1.0 cm or smaller.
Journal ArticleDOI
The Predictive Value of Tumor Mutation Burden on Efficacy of Immune Checkpoint Inhibitors in Cancers: A Systematic Review and Meta-Analysis
TL;DR: TMB and PD-L1 expression were capable to predict improved ORR of ICIs after stratification of each other, with tiny heterogeneity, and targeted next generation sequencing for estimating tumor mutation burden in clinic should be standardized to eliminate heterogeneity in the future.
Journal ArticleDOI
Diagnostic and Prognostic Value of Serum Interleukin-6 in Colorectal Cancer.
Jinming Xu,Yao Ye,Honghe Zhang,Maciej Szmitkowski,Mj J. Mäkinen,Peiwei Li,Dajing Xia,Jun Yang,Yihua Wu,Han Wu +9 more
TL;DR: It is confirmed that serum IL-6 may be a potential biomarker for CRC diagnosis, and the high serumIL-6 level was associated with poor prognosis for both CRC overall survival and disease-free survival.
Journal ArticleDOI
Association between markers of glucose metabolism and risk of colorectal cancer
Jinming Xu,Yao Ye,Han Wu,Penelope J. Duerksen-Hughes,Honghe Zhang,Peiwei Li,Jian Huang,Jun Yang,Yihua Wu,Dajing Xia +9 more
TL;DR: The real-time composite index HOMA-IR is a better indicator for CRC risk than are fasting glucose and fasting insulin and the relative long-term markers, HbA1c and C peptide, are also valid predictors for CRCrisk.